Literature DB >> 8035658

Maturity-onset diabetes of the young.

S S Fajans1, G I Bell, D W Bowden, J B Halter, K S Polonsky.   

Abstract

Maturity-onset diabetes of the young (MODY) is a subtype of noninsulin dependent diabetes mellitus (NIDDM). It is characterized by an early age of onset and autosomal dominant mode of inheritance. These features and the availability of large multigenerational pedigrees make MODY useful for genetic studies of diabetes. In the large, 5-generational RW pedigree, MODY is tightly linked to genetic markers on chromosome 20q. Affected subjects in this family show abnormalities of carbohydrate metabolism varying from impaired glucose tolerance (IGT) to severe diabetes. Approximately 30% of diabetic subjects become insulin requiring and vascular complications occur. MODY is also linked to the glucokinase gene on chromosome 7p and many different mutations associated with MODY have been identified in this gene. MODY due to mutations in the glucokinase gene is a relatively mild form of diabetes with mild fasting hyperglycemia and IGT in the majority. IT is rarely insulin requiring and rarely has vascular complications. Clinical studies indicate that the genetic or primary defect in MODY is characterized by deranged and deficient insulin secretion and not by insulin resistance and that there are quantitative and qualitative differences in insulin secretory defects which differentiate subjects with MODY due to glucokinase mutations from those with mutations in the gene on chromosome 20q. These differences correlate with the severity of diabetes between these two genetic forms of MODY.

Entities:  

Mesh:

Year:  1994        PMID: 8035658     DOI: 10.1016/0024-3205(94)90052-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations.

Authors:  A Grimberg; R J Ferry; A Kelly; S Koo-McCoy; K Polonsky; B Glaser; M A Permutt; L Aguilar-Bryan; D Stafford; P S Thornton; L Baker; C A Stanley
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene.

Authors:  M Stoffel; M M Le Beau; R Espinosa; S F Bohlander; D Le Paslier; D Cohen; K S Xiang; N J Cox; S S Fajans; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 3.  When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.

Authors:  Sara Althari; Anna L Gloyn
Journal:  Rev Diabet Stud       Date:  2016-02-10

4.  Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene.

Authors:  T Lindner; C Gragnoli; H Furuta; B N Cockburn; C Petzold; H Rietzsch; U Weiss; J Schulze; G I Bell
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A).

Authors:  S S Fajans; G I Bell
Journal:  Diabetologia       Date:  2007-09-22       Impact factor: 10.122

6.  3T3-L1 adipocytes induce dysfunction of MIN6 insulin-secreting cells via multiple pathways mediated by secretory factors in a co-culture system.

Authors:  Yu-Feng Zhao; Dan-Dan Feng; Maria Hernandez; Chen Chen
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

7.  The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Authors:  B M Shields; T J McDonald; S Ellard; M J Campbell; C Hyde; A T Hattersley
Journal:  Diabetologia       Date:  2012-01-05       Impact factor: 10.122

8.  Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes.

Authors:  Jaime L Peters; Rob Anderson; Chris Hyde
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

Review 9.  MODY: history, genetics, pathophysiology, and clinical decision making.

Authors:  Stefan S Fajans; Graeme I Bell
Journal:  Diabetes Care       Date:  2011-08       Impact factor: 19.112

10.  Strategies to identify individuals with monogenic diabetes: results of an economic evaluation.

Authors:  Jaime L Peters; Rob Anderson; Beverley Shields; Sophie King; Michelle Hudson; Maggie Shepherd; Timothy James McDonald; Ewan Pearson; Andrew Hattersley; Chris Hyde
Journal:  BMJ Open       Date:  2020-03-18       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.